Globus Medical (GMED) Net Cash Flow (2011 - 2026)

Globus Medical's Net Cash Flow history runs 16 years deep, the most recent figure standing at $37.9 million for Q1 2026.

• Quarterly Net Cash Flow rose 111.6% year-over-year to $37.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83.9 million (down 16.21% YoY) and the FY2025 annual result came in at -$280.7 million, down 188.59% from the prior year.
• Net Cash Flow was $37.9 million for Q1 2026 at Globus Medical, down from $150.4 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $208.3 million in Q3 2024 and bottomed at -$326.7 million in Q1 2025.
• A 5-year average of $20.4 million and a median of $37.9 million in 2026 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2023 — Net Cash Flow soared 1000.68% — and 2025, when it sank 568.12%.
• Globus Medical's Net Cash Flow stood at $17.1 million in 2022, then surged by 1000.68% to $188.0 million in 2023, then declined by 11.74% to $166.0 million in 2024, then fell by 9.4% to $150.4 million in 2025, then sank by 74.8% to $37.9 million in 2026.
• Business Quant data shows GMED's Net Cash Flow at $37.9 million in Q1 2026, $150.4 million in Q4 2025, and $141.8 million in Q3 2025.